Literature DB >> 9292803

Suppression of matrix metalloproteinase-3 synthesis by interleukin-4 in human articular chondrocytes.

O Nemoto1, H Yamada, T Kikuchi, M Shinmei, K Obata, H Sato, M Seiki, M Shimmei.   

Abstract

OBJECTIVE: To evaluate the effect of interleukin-4 (IL-4) on IL-1 induced matrix metalloproteinase-3 (MMP-3) and tissue inhibitor of metalloproteinase-1 (TIMP-1) production by human articular chondrocytes.
METHODS: Monolayer cell culture of chondrocytes was obtained from human articular cartilage from patella within 24 h after death. MMP-3 and TIMP-1 protein levels were determined by ELISA. MMP-3 activity was assayed as caseinase activity. Amounts of MMP-3 and TIMP-1 mRNA were measured by Northern blot analysis.
RESULTS: IL-4 suppressed IL-1 stimulated MMP-3 protein and enzyme activity. Moreover, IL-4 suppressed IL-1 induced MMP-3 mRNA. In contrast, IL-4 did not alter the level of TIMP-1 protein and mRNA.
CONCLUSION: IL-4 may be implicated as a protective mediator of joint destruction seen in inflammatory arthritis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9292803

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

1.  Protective effects of interleukin-4 on tissue destruction and morphological changes of bovine nasal chondrocytes in vitro.

Authors:  Maryam Yadegari; Mahmoud Orazizadeh; Mahmoud Hashemitabar; Ali Khodadadi
Journal:  Iran Biomed J       Date:  2013

2.  T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm.

Authors:  Uwe Schönbeck; Galina K Sukhova; Norbert Gerdes; Peter Libby
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

3.  IL-4 inhibition of IL-1 induced Matrix metalloproteinase-3 (MMP-3) expression in human fibroblasts involves decreased AP-1 activation via negative crosstalk involving of Jun N-terminal kinase (JNK).

Authors:  Mariah Chambers; Garrett Kirkpatrick; Michel Evans; Grzegorz Gorski; Sara Foster; Ruth C Borghaei
Journal:  Exp Cell Res       Date:  2013-04-19       Impact factor: 3.905

4.  Interleukin-4 suppresses IL-1-induced expression of matrix metalloproteinase-3 in human gingival fibroblasts.

Authors:  Kosunique Jenkins; Masoud Javadi; Ruth Carter Borghaei
Journal:  J Periodontol       Date:  2004-02       Impact factor: 6.993

5.  Common variants within the interleukin 4 receptor alpha gene (IL4R) are associated with susceptibility to osteoarthritis.

Authors:  Tracy Forster; Kay Chapman; John Loughlin
Journal:  Hum Genet       Date:  2004-01-24       Impact factor: 4.132

6.  The involvement of interleukin-1 and interleukin-4 in the response of human annulus fibrosus cells to cyclic tensile strain: an altered mechanotransduction pathway with degeneration.

Authors:  Hamish T J Gilbert; Judith A Hoyland; Anthony J Freemont; Sarah J Millward-Sadler
Journal:  Arthritis Res Ther       Date:  2011-01-28       Impact factor: 5.156

7.  Interleukin-4 inhibition of interleukin-1-induced expression of matrix metalloproteinase-3 (MMP-3) is independent of lipoxygenase and PPARgamma activation in human gingival fibroblasts.

Authors:  Denise Stewart; Masoud Javadi; Mariah Chambers; Chad Gunsolly; Grzegorz Gorski; Ruth C Borghaei
Journal:  BMC Mol Biol       Date:  2007-02-23       Impact factor: 2.946

8.  Integrin-regulated secretion of interleukin 4: A novel pathway of mechanotransduction in human articular chondrocytes.

Authors:  S J Millward-Sadler; M O Wright; H Lee; K Nishida; H Caldwell; G Nuki; D M Salter
Journal:  J Cell Biol       Date:  1999-04-05       Impact factor: 10.539

9.  Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.

Authors:  L A Joosten; E Lubberts; M M Helsen; T Saxne; C J Coenen-de Roo ; D Heinegård; W B van den Berg
Journal:  Arthritis Res       Date:  1999-10-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.